Quick answer
Beta Bionics, Inc. (BBNX) reported revenue of $100.3M and net loss of $73.2M for the fiscal year ended 2025-12-31, up 53.9% from $65.1M the year before, per its 10-K filed with the SEC on 2026-02-24.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $100.3M | -$73.2M | — |
| 2024 (FY ending 2024-12-31) | $65.1M | -$54.8M | — |
| 2023 (FY ending 2023-12-31) | $12.0M | -$44.1M | — |
Frequently asked questions
What is Beta Bionics, Inc.'s annual revenue?
Beta Bionics, Inc. (BBNX) reported revenue of $100.3M and net loss of $73.2M for the fiscal year ended 2025-12-31, up 53.9% from $65.1M the year before, per its 10-K filed with the SEC on 2026-02-24.
What is BBNX's profit margin?
Beta Bionics, Inc.'s net margin was -73.0% in the fiscal year ended 2025-12-31.
Related
- BAND revenue, net income and debt history (Bandwidth Inc.)
- BAX revenue, net income and debt history (Baxter International Inc.)
- BBAI revenue, net income and debt history (BigBear.ai Holdings, Inc.)
- BBT revenue, net income and debt history (Beacon Financial Corp)
- BBY revenue, net income and debt history (Best Buy Co., Inc.)
- BC revenue, net income and debt history (Brunswick Corporation)
- BCPC revenue, net income and debt history (Balchem Corporation)
- BCYC revenue, net income and debt history (Bicycle Therapeutics plc)
Last updated Oct 23, 2026, 7:21 AM ET. Data only, not financial or tax advice.
Related answers
Tools & live data
What's Moving Right Now
#1 Nasdaq-100 moverAMD $507.93 -8.10%Nasdaq, as of Oct 22, 2026 4:15 PM ET
Trading halts18 halts in Nasdaq's current feedNasdaq Trader feed, checked Oct 23, 7:30 AM ET
Earnings & SEC 8-Ks14 companies report Oct 23 · 8-Ks todayNasdaq earnings calendar, SEC EDGAR